Base de datos : ins
Búsqueda : INTERLEUCINA-18 [Descritor de assunto]
Referencias encontradas : 2 [refinar]
Mostrando: 1 .. 2   en el formato [Detallado]

página 1 de 1

  1 / 2 ins  
              next record last record
selecciona
para imprimir
Id:8328
Autor:Vincenti, D; Carrara, S; Butera, O; Bizzoni, F; Casetti, R; Girardi, E; Goletti, D
Título:Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study^ien ..-
Fuente:Oxford; Blackwell Scientific Publications; 2007. 91-8 p. ^btab, ^bgraf.
Resumen:Tuberculosis is the most frequent co-infection in human immunodeficiency virus (HIV)-infected individuals, and which still presents diagnostic difficulties. Recently we set up an assay based on interferon (IFN)-gamma response to region of difference 1 (RD1) peptides selected by computational analysis which is associated with active Mycobacterium tuberculosis replication. The objective of this study was to investigate the response to RD1 selected peptides in HIV-1-infected individuals in a clinical setting. The mechanisms of this immune response and comparison with other immune assays were also investigated. A total of 111 HIV-infected individuals with symptoms and signs consistent with active tuberculosis were enrolled prospectively. Interferon (IFN)-gamma responses to RD1 selected peptides and recall antigens were evaluated by enzyme-linked immunospot assay. Results were correlated with CD4(+) T cell counts, individuals' characteristics, tuberculin skin test, QuantiFERON-TB Gold and T-SPOT.TB. Results from 21 (19 percent) individuals were indeterminate due to in vitro cell anergy. Among 'non-anergic' individuals, sensitivity for active tuberculosis of the assay based on RD1 selected peptides was 67 percent (24 of 36), specificity was 94 percent (three of 54). The assay also resulted positive in cases of extra-pulmonary and smear-negative pulmonary active tuberculosis. The response was mediated by CD4(+) effector/memory T cells and correlated with CD4(+) T cell counts, but not with plasma HIV-RNA load. Moreover, the RD1 selected peptides assay had the highest diagnostic odds ratio for active tuberculosis compared to tuberculin skin test (TST), QuantiFERON-TB Gold and T-SPOT.TB. RD1 selected peptides assay is associated with M. tuberculosis replication in HIV-infected individuals, although T cell anergy remains an important obstacle to be overcome before the test can be proposed as a diagnostic tool. (AU)^ien.
Descriptores:Linfocitos T
VIH
Interleucina-18
Límites:Humanos
Localización:PE14.1


  2 / 2 ins  
              first record previous record
selecciona
para imprimir
Texto completo
Id:4715
Autor:Valverde, Ada; Romero, Soledad; Cabezas Sánchez, César.
Título:Inmunofluorescencia indirecta como prueba alternativa para la confirmación diagnóstica de infección por VIH en el Perú / Indirect inmunofluorescence as an alternative test for the confirmation test for VIH in Peru
Resumen:Desde 1990 en el INS Perú se viene utilizando la técnica de Western Blot (WB) para la confirmación del Diagnóstico de VIH. En este estudio se evalua la prueba de inmunofluorescencia indirecta (IFI) como una alternativa de confirmación al Western Blot. Se utilizaron 132 sueros de la seroteca de la División de Virología del INS Perú con diagnóstico previo de VIH por WB. Para el diagnóstico de IFI se usó un kit producido en el Centro Nacional de Referencia de SIDA (Chile-Argentina). De los 132 sueros procesados 56 (42,4 por ciento) correspondieron a Western Blot positivo, 52 (39,4por ciento) a Western Blot negativos y 24 (18,2) con Western Blot indeterminado. La sensibilidad y especificidad de la técnica IFI en comparación con la de Western Blot fue de 98,2 por ciento y 98 por ciento respectivamente. Los valores predictivo positivo y negativo fueron 98,2 por ciento y 100 por ciento, respectivamente. Estos resultados permiten incorporar a la técnica de IFI como una prueba alternativa para la confirmación de diagnóstico de infección por VIH.
Descriptores:VIH
SINDROME DE INMUNODEFICIENCIA ADQUIRIDA/diagnóstico
INTERLEUCINA-18
PERU
Medio Electrónico:http://www.bvs.ins.gob.pe/insprint/rev/med_exp/sp1997/a04v14n1.pdf / es
Localización:PE14.1, Rev. med. exp.;14(1):19-21, ene.-jun. 1997



página 1 de 1
   


Refinar la búsqueda
  Base de datos : ins Formulario avanzado   
Buscar por : Formulario libre   

    Buscar en el campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/OPS/OMS - Centro Latinoamericano y del Caribe de Información en Ciencias de la Salud